Undruggable

Join us for a Q&A webinar event and explore Undruggable, a special edition podcast series produced by The Scientist’s Creative Services Team and brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines.

Beginning with the introduction of aspirin at the start of the 20th century, there have been three major waves of innovation in drug discovery. While breakthrough discoveries have been made, 85% of disease targets are still considered undruggable, which represents an ongoing barrier to discovering medicines for complex diseases like cancer and autoimmune conditions. Now, the fourth wave of innovation is here, led by new types of multispecific medicines that will radically alter our concept of how drugs can work and pave the way for new solutions.

Webinar 1 - Episodes 1 and 2, The Next Wave of Drug Development and Drugging the Undruggable: The Biology of PROTACs
November 3, 2021 @ 2:30 PM ET
Webinar 2 - Episode 3, Discovery at the DNA Encoded Library
November 10, 2021 @ 2:30 PM ET
Webinar 3 - Episode 4, The Emerging Induced Proximity Toolkit
November 17, 2021 @ 2:00 PM ET

Visit this page to access the Undruggable podcast series!

Episode 1 - The Next Wave of Drug Development,
October 21, 2021
Episode 2 - Drugging the Undruggable: The Biology of PROTACs,
October 28, 2021
Episode 3 - Discovery at the DNA Encoded Library,
November 4, 2021
Episode 4 - The Emerging Induced Proximity Toolkit,
November 11, 2021
Episode 5 - Induced Proximity for Cancer and Beyond,
November 18, 2021

Undruggable - A special 3-part Q&A series

Sign up for the series now

TS_Webinar_Amgen_Series 2_Undruggable_IO#403179